Open Access
Open access
Antimicrobial Agents and Chemotherapy, volume 50, issue 7, pages 2500-2505

The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics

Long Katherine S 1
Poehlsgaard Jacob 2
Kehrenberg Corinna 3
Schwarz Stefan 3
Vester Birte 2
Publication typeJournal Article
Publication date2006-07-06
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor4.9
ISSN00664804, 10986596
PubMed ID:  16801432
Pharmacology
Infectious Diseases
Pharmacology (medical)
Abstract
ABSTRACT A novel multidrug resistance phenotype mediated by the Cfr rRNA methyltransferase is observed in Staphylococcus aureus and Escherichia coli. The cfr gene has previously been identified as a phenicol and lincosamide resistance gene on plasmids isolated from Staphylococcus spp. of animal origin and recently shown to encode a methyltransferase that modifies 23S rRNA at A2503. Antimicrobial susceptibility testing shows that S. aureus and E. coli strains expressing the cfr gene exhibit elevated MICs to a number of chemically unrelated drugs. The phenotype is named PhLOPSA for resistance to the following drug classes: Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Each of these five drug classes contains important antimicrobial agents that are currently used in human and/or veterinary medicine. We find that binding of the PhLOPSA drugs, which bind to overlapping sites at the peptidyl transferase center that abut nucleotide A2503, is perturbed upon Cfr-mediated methylation. Decreased drug binding to Cfr-methylated ribosomes has been confirmed by footprinting analysis. No other rRNA methyltransferase is known to confer resistance to five chemically distinct classes of antimicrobials. In addition, the findings described in this study represent the first report of a gene conferring transferable resistance to pleuromutilins and oxazolidinones.

Citations by journals

10
20
30
40
50
60
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 59, 10.79%
Antimicrobial Agents and Chemotherapy
59 publications, 10.79%
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 49, 8.96%
Journal of Antimicrobial Chemotherapy
49 publications, 8.96%
Antibiotics
Antibiotics, 17, 3.11%
Antibiotics
17 publications, 3.11%
Frontiers in Microbiology
Frontiers in Microbiology, 16, 2.93%
Frontiers in Microbiology
16 publications, 2.93%
Diagnostic Microbiology and Infectious Disease
Diagnostic Microbiology and Infectious Disease, 16, 2.93%
Diagnostic Microbiology and Infectious Disease
16 publications, 2.93%
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, 14, 2.56%
Journal of Global Antimicrobial Resistance
14 publications, 2.56%
Veterinary Microbiology
Veterinary Microbiology, 12, 2.19%
Veterinary Microbiology
12 publications, 2.19%
Nucleic Acids Research
Nucleic Acids Research, 8, 1.46%
Nucleic Acids Research
8 publications, 1.46%
PLoS ONE
PLoS ONE, 8, 1.46%
PLoS ONE
8 publications, 1.46%
Clinical Microbiology and Infection
Clinical Microbiology and Infection, 7, 1.28%
Clinical Microbiology and Infection
7 publications, 1.28%
International Journal of Medical Microbiology
International Journal of Medical Microbiology, 7, 1.28%
International Journal of Medical Microbiology
7 publications, 1.28%
Microbiology spectrum
Microbiology spectrum, 6, 1.1%
Microbiology spectrum
6 publications, 1.1%
Expert Review of Anti-Infective Therapy
Expert Review of Anti-Infective Therapy, 6, 1.1%
Expert Review of Anti-Infective Therapy
6 publications, 1.1%
Future Microbiology
Future Microbiology, 5, 0.91%
Future Microbiology
5 publications, 0.91%
Microorganisms
Microorganisms, 5, 0.91%
Microorganisms
5 publications, 0.91%
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 5, 0.91%
International Journal of Antimicrobial Agents
5 publications, 0.91%
EFSA Journal
EFSA Journal, 5, 0.91%
EFSA Journal
5 publications, 0.91%
Science
Science, 5, 0.91%
Science
5 publications, 0.91%
Clinical Microbiology Reviews
Clinical Microbiology Reviews, 5, 0.91%
Clinical Microbiology Reviews
5 publications, 0.91%
Scientific Reports
Scientific Reports, 4, 0.73%
Scientific Reports
4 publications, 0.73%
European Journal of Clinical Microbiology and Infectious Diseases
European Journal of Clinical Microbiology and Infectious Diseases, 4, 0.73%
European Journal of Clinical Microbiology and Infectious Diseases
4 publications, 0.73%
Journal of Biological Chemistry
Journal of Biological Chemistry, 4, 0.73%
Journal of Biological Chemistry
4 publications, 0.73%
Molecular Microbiology
Molecular Microbiology, 4, 0.73%
Molecular Microbiology
4 publications, 0.73%
Journal of the American Chemical Society
Journal of the American Chemical Society, 4, 0.73%
Journal of the American Chemical Society
4 publications, 0.73%
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 4, 0.73%
Proceedings of the National Academy of Sciences of the United States of America
4 publications, 0.73%
Microbial Drug Resistance
Microbial Drug Resistance, 3, 0.55%
Microbial Drug Resistance
3 publications, 0.55%
Journal of Medical Microbiology
Journal of Medical Microbiology, 3, 0.55%
Journal of Medical Microbiology
3 publications, 0.55%
Microbiology
Microbiology, 3, 0.55%
Microbiology
3 publications, 0.55%
Molecules
Molecules, 3, 0.55%
Molecules
3 publications, 0.55%
10
20
30
40
50
60

Citations by publishers

20
40
60
80
100
120
Elsevier
Elsevier, 120, 21.94%
Elsevier
120 publications, 21.94%
American Society for Microbiology
American Society for Microbiology, 83, 15.17%
American Society for Microbiology
83 publications, 15.17%
Oxford University Press
Oxford University Press, 64, 11.7%
Oxford University Press
64 publications, 11.7%
Springer Nature
Springer Nature, 45, 8.23%
Springer Nature
45 publications, 8.23%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 36, 6.58%
Multidisciplinary Digital Publishing Institute (MDPI)
36 publications, 6.58%
Frontiers Media S.A.
Frontiers Media S.A., 22, 4.02%
Frontiers Media S.A.
22 publications, 4.02%
Wiley
Wiley, 22, 4.02%
Wiley
22 publications, 4.02%
Taylor & Francis
Taylor & Francis, 13, 2.38%
Taylor & Francis
13 publications, 2.38%
American Chemical Society (ACS)
American Chemical Society (ACS), 12, 2.19%
American Chemical Society (ACS)
12 publications, 2.19%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 9, 1.65%
Public Library of Science (PLoS)
9 publications, 1.65%
Microbiology Society
Microbiology Society, 6, 1.1%
Microbiology Society
6 publications, 1.1%
Future Medicine
Future Medicine, 5, 0.91%
Future Medicine
5 publications, 0.91%
Mary Ann Liebert
Mary Ann Liebert, 5, 0.91%
Mary Ann Liebert
5 publications, 0.91%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 5, 0.91%
American Association for the Advancement of Science (AAAS)
5 publications, 0.91%
American Society for Biochemistry and Molecular Biology
American Society for Biochemistry and Molecular Biology, 4, 0.73%
American Society for Biochemistry and Molecular Biology
4 publications, 0.73%
Proceedings of the National Academy of Sciences (PNAS)
Proceedings of the National Academy of Sciences (PNAS), 4, 0.73%
Proceedings of the National Academy of Sciences (PNAS)
4 publications, 0.73%
Bentham Science
Bentham Science, 3, 0.55%
Bentham Science
3 publications, 0.55%
Wolters Kluwer Health
Wolters Kluwer Health, 3, 0.55%
Wolters Kluwer Health
3 publications, 0.55%
SAGE
SAGE, 3, 0.55%
SAGE
3 publications, 0.55%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 3, 0.55%
Cold Spring Harbor Laboratory
3 publications, 0.55%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 2, 0.37%
Royal Society of Chemistry (RSC)
2 publications, 0.37%
Cambridge University Press
Cambridge University Press, 2, 0.37%
Cambridge University Press
2 publications, 0.37%
Hindawi Limited
Hindawi Limited, 2, 0.37%
Hindawi Limited
2 publications, 0.37%
Pleiades Publishing
Pleiades Publishing, 1, 0.18%
Pleiades Publishing
1 publication, 0.18%
PeerJ
PeerJ, 1, 0.18%
PeerJ
1 publication, 0.18%
American Society of Agronomy
American Society of Agronomy, 1, 0.18%
American Society of Agronomy
1 publication, 0.18%
Kowsar Publishing Company, 1, 0.18%
Kowsar Publishing Company
1 publication, 0.18%
Walter de Gruyter
Walter de Gruyter, 1, 0.18%
Walter de Gruyter
1 publication, 0.18%
Pan American Health Organization/Organizacion Panamericana de la Salud, 1, 0.18%
Pan American Health Organization/Organizacion Panamericana de la Salud
1 publication, 0.18%
20
40
60
80
100
120
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Long K. S. et al. The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics // Antimicrobial Agents and Chemotherapy. 2006. Vol. 50. No. 7. pp. 2500-2505.
GOST all authors (up to 50) Copy
Long K. S., Poehlsgaard J., Kehrenberg C., Schwarz S., Vester B. The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics // Antimicrobial Agents and Chemotherapy. 2006. Vol. 50. No. 7. pp. 2500-2505.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1128/AAC.00131-06
UR - https://doi.org/10.1128%2FAAC.00131-06
TI - The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics
T2 - Antimicrobial Agents and Chemotherapy
AU - Long, Katherine S
AU - Poehlsgaard, Jacob
AU - Kehrenberg, Corinna
AU - Schwarz, Stefan
AU - Vester, Birte
PY - 2006
DA - 2006/07/06 00:00:00
PB - American Society for Microbiology
SP - 2500-2505
IS - 7
VL - 50
PMID - 16801432
SN - 0066-4804
SN - 1098-6596
ER -
BibTex |
Cite this
BibTex Copy
@article{2006_Long,
author = {Katherine S Long and Jacob Poehlsgaard and Corinna Kehrenberg and Stefan Schwarz and Birte Vester},
title = {The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2006},
volume = {50},
publisher = {American Society for Microbiology},
month = {jul},
url = {https://doi.org/10.1128%2FAAC.00131-06},
number = {7},
pages = {2500--2505},
doi = {10.1128/AAC.00131-06}
}
MLA
Cite this
MLA Copy
Long, Katherine S., et al. “The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics.” Antimicrobial Agents and Chemotherapy, vol. 50, no. 7, Jul. 2006, pp. 2500-2505. https://doi.org/10.1128%2FAAC.00131-06.
Found error?